Reviews in Medical Virology

Papers
(The H4-Index of Reviews in Medical Virology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
SARS‐CoV‐2 in digital era: Diagnostic techniques and importance of nucleic acid quantification with digital PCRs411
Role of Gut Microbiota in Dengue280
Hospitalised Dengue Patients and Risk of Hypertension: A Systematic Review and Meta‐Analysis121
Correction to “Relative Efficacy, Effectiveness and Safety of Newer And/Or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory‐Confirmed Influenza in Individuals Aged 18 Years and Ov87
Human Metapneumovirus: A Review of Its Epidemiology, Clinical Features, Public Health Implications and Treatment Options84
Clinical performance of rapid antigen tests in comparison to RT‐PCR for SARS‐COV‐2 diagnosis in Omicron variant: A systematic review and meta‐analysis84
73
Risk of kidney and liver diseases after COVID‐19 infection: A systematic review and meta‐analysis70
COVID‐19 in hematopoietic stem‐cell transplant recipients: A systematic review and meta‐analysis of clinical characteristics and outcomes65
Duration of protective immunity following COVID‐19 vaccination of individuals with underlying health conditions: A rapid review63
Insight into the Enterovirus A71: A review62
62
Cover Image60
Test accuracy of rapid diagnostic tests and reverse‐transcription polymerase chain reaction against virus isolation in cell culture for assessing SARS‐CoV‐2 infectivity: Systematic review and meta‐ana54
The Association Between Male Viral Infections and Infertility: A Systematic Review and Meta‐Analysis53
Humoral immune response to two doses of COVID‐19 mRNA‐based vaccines in people living with HIV: A systematic review and meta‐analysis47
Next Generation RNA/Protein‐Carrying Vector With Pleiotropic Activity47
Maintaining an international response to zoonoses44
Virus‐Induced Host Chemokine CCL2 in COVID‐19 Pathogenesis: Potential Prognostic Marker and Target of Anti‐Inflammatory Strategy42
The role of cytokines and their antagonists in the treatment of COVID‐19 patients42
42
Norovirus outbreaks in China, 2000–2018: A systematic review40
Epidemiology, biosafety, and biosecurity of Avian Influenza: Insights from the East Mediterranean region40
39
Commentary on ‘Confounding Variable in Recent Clinical Trial on ORFV‐Based Therapeutics’37
Azvudine versus Paxlovid in COVID‐19: A systematic review and meta‐analysis35
Electroencephalographic findings post‐COVID‐19 vaccination: A systematic review of case reports and case series35
Long‐term side effects and lingering symptoms post COVID‐19 recovery34
Efficacy and safety of long‐acting cabotegravir versus oral tenofovir disoproxil fumarate‐emtricitabine as HIV pre‐exposure prophylaxis: A systematic review and meta‐analysis34
Issue Information33
The programed death‐1/programed death ligand‐1 axis and its potential as a therapeutic target for virus‐associated tumours33
Antioxidant/anti‐inflammatory effect of Mg2+ in coronavirus disease 2019 (COVID‐19)32
Laboratory‐based testing for hepatitis C infection using dried blood spot samples: A systematic review and meta‐analysis of diagnostic accuracy32
0.21239686012268